Nuo Therapeutics, Inc. (AURX)

Market Cap	67.60M +179.0%
Revenue (ttm)	2.61M +123.7%
Net Income	-2.43M
EPS	-0.05
Shares Out	48.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,200
Average Volume	4,329
Open	1.400
Previous Close	1.400
Day's Range	1.400 - 1.500
52-Week Range	1.000 - 3.230
Beta	-926.26
RSI	35.40
Earnings Date	Apr 1, 2026

About Nuo Therapeutics

Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and ch...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: AURX

Financial Performance

In 2024, Nuo Therapeutics's revenue was $1.37 million, an increase of 124.34% compared to the previous year's $608,525. Losses were -$2.32 million, -26.73% less than in 2023.